Legend Biotech (LEGN) EPS (Weighted Average and Diluted) (2019 - 2025)
Historic EPS (Weighted Average and Diluted) for Legend Biotech (LEGN) over the last 6 years, with Q3 2025 value amounting to -$53412.5.
- Legend Biotech's EPS (Weighted Average and Diluted) rose 7613.25% to -$53412.5 in Q3 2025 from the same period last year, while for Sep 2025 it was -$53412.5, marking a year-over-year increase of 7613.25%. This contributed to the annual value of -$0.48 for FY2024, which is 6734.69% up from last year.
- As of Q3 2025, Legend Biotech's EPS (Weighted Average and Diluted) stood at -$53412.5, which was up 7613.25% from -$200348.4 recorded in Q2 2025.
- Legend Biotech's 5-year EPS (Weighted Average and Diluted) high stood at -$0.1 for Q1 2022, and its period low was -$948228.6 during Q2 2024.
- Moreover, its 4-year median value for EPS (Weighted Average and Diluted) was -$0.43 (2021), whereas its average is -$158419.8.
- In the last 5 years, Legend Biotech's EPS (Weighted Average and Diluted) tumbled by 7091.96% in 2021 and then skyrocketed by 7887.13% in 2025.
- Quarter analysis of 4 years shows Legend Biotech's EPS (Weighted Average and Diluted) stood at -$0.3 in 2021, then surged by 65.28% to -$0.1 in 2022, then plummeted by 213951973.68% to -$223787.5 in 2024, then soared by 76.13% to -$53412.5 in 2025.
- Its EPS (Weighted Average and Diluted) was -$53412.5 in Q3 2025, compared to -$200348.4 in Q2 2025 and -$223787.5 in Q3 2024.